- REPL
- REPLIMUNE GROUP INC
-
2.18-0.11 (-4.61%) 04/16 09:54 EST(20m-delayed)
- Signals
- Analysis
- Financials
- Charts
- Dividends
AI Signals
Trade Signals
- 3 months
- 6 months
- 1 year
As a biotechnology company, it develops tumor solubility immune gene therapy to treat cancer.